IMM 0.00% 39.5¢ immutep limited

Ann: CVac shows overall survival benefit, page-45

  1. 922 Posts.
    lightbulb Created with Sketch. 304
    This is fantastic news for anyone who suffers with this insidious disease. I can't see how the FDA cannot be compelled to let this treatment into the market for compassionate reasons alone.

    OC is by far one of the worst cancers to beat, as it is usually only diagnosed after the disease has developed to a later (mostly untreatable) stage. Anything that can possibly give sufferers more time to spend with their loved ones, would be graciously accepted I am sure. These people generally have nothing to lose and it would be nothing short of cruel to not allow them to at least have a chance of living a little bit longer. And you never know - once it is out there it may well prove to be more valuable than what it has already proved.

    I only hope for the sake of sufferers everywhere, that Prima can find a partner to help get this to the people that need it most.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
39.5¢
Change
0.000(0.00%)
Mkt cap ! $588.3M
Open High Low Value Volume
38.5¢ 41.0¢ 38.5¢ $915.1K 2.296M

Buyers (Bids)

No. Vol. Price($)
6 45266 39.5¢
 

Sellers (Offers)

Price($) Vol. No.
40.0¢ 230907 10
View Market Depth
Last trade - 12.00pm 03/09/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.